Oracle BI Suite Powers Clinical Development Analytics 
Oracle is shipping a new BI-based set of analytics to help life sciences organizations operate their clinical programs more efficiently, get more timely access to information so they can make informed decision and even help accelerate the development of new drugs.
Oracle Clinical Development Analytics is built on Oracle Business Intelligence Suite Enterprise Edition Plus. The package is designed to improve the transparency between contract research organizations (CROs) and sponsors, to improve communications between disparate team members so they can more efficiently, an Oracle executive said.
“Life Sciences organizations require systems that can improve the quality and timeliness of their clinical information to enhance the overall effectiveness of their programs,” said Neil de Crescenzo, senior vice president of Oracle Health Sciences, in a statement.
Oracle Clinical Development Analytics is a BI application that enables life sciences executives, managers, and team members to make decisions based on current, consistent performance management information that has typically been stored in various systems, de Crescenzo added.
Oracle Clinical Development Analytics is has a built-in clinical warehouse and ad-hoc report builder to letusers rapidly build their own reports based on pre-calculated metrics. Further, the application’s centralized warehousing architecture helps CROs and sponsors working on pharmaceutical, device, and biotechnology projects better control IT costs by eliminating the need for many different reporting systems, de Crescenzo added.
One analyst remarked that Oracle’s decision to introduce a BI-based component for its growing suite of life cycle offerings will benefit users.
“Working in conjunction with the Oracle Life Sciences Data Hub, Oracle Clinical Development Analytics is an additional piece in Oracle’s increasingly comprehensive eClinical suite of offerings for life sciences. We see Oracle’s decision [to create] a comprehensive [life sciences] product offering as market leading,” wrote Alan Louie, Research Director, IDC Health Insights, in a recent report.
|
